MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings EV - Enterprise Value 2011-2026 | ONVO
Annual EV - Enterprise Value Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.05 M | 594 K | -1.78 M | -16.7 M | 28.9 M | 83.2 M | 94.5 M | 228 M | 195 M | 316 M | 381 M | 5.43 B | 191 M | -329 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.43 B | -16.7 M | 494 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 118.88 | -0.73 % | $ 36.1 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 19.95 | -2.97 % | $ 215 M |  China |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 21.35 | 21.51 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 1.41 | -0.5 % | $ 1.88 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 24.45 | -0.69 % | $ 679 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 181.78 | 0.62 % | $ 9.01 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 194.57 | -1.78 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 2.15 | -2.45 % | $ 9.51 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 524.75 | 1.2 % | $ 15.1 B | USA |
 |
Illumina
ILMN
|
15.3 B | $ 131.47 | -0.6 % | $ 20.9 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 16.25 | 0.46 % | $ 491 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.38 | -3.51 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.31 | -1.17 % | $ 2.02 B | USA |
 |
Guardant Health
GH
|
15.2 B | $ 85.85 | 1.17 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 29.01 | -0.21 % | $ 20 B | Niderland |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.85 | -2.73 % | $ 92.5 K | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.2 | 4.27 % | $ 5.05 M | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 117.72 | 1.04 % | $ 9.71 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 269.19 | 0.86 % | $ 22.4 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.78 | -1.74 % | $ 283 M | USA |
 |
Celcuity
CELC
|
5.57 B | $ 124.46 | 0.8 % | $ 5.82 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 5.16 | -0.58 % | $ 478 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.6 | 0.05 % | $ 2.67 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 83.21 | -0.87 % | $ 5.62 B | USA |
 |
Neuronetics
STIM
|
168 M | $ 1.38 | -1.08 % | $ 91 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 194.16 | 1.48 % | $ 21.6 B | USA |
 |
ENDRA Life Sciences
NDRA
|
4.49 M | $ 5.13 | -0.19 % | $ 4.04 M | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 522.3 | -1.73 % | $ 197 B | USA |
 |
Trinity Biotech plc
TRIB
|
133 M | $ 0.71 | 1.07 % | $ 61.9 M | Irlanda |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |